Browse by:
Health Care

Advocates say 'perfect storm' of possible cuts threatens mental health care


Jim, who has struggled with alcoholism and drug addiction, credits Medicaid with helping him reunite with his children last October for the first time in two and a half years.

Bristol Hospital building inpatient senior behavioral health unit

John Stearns |

Bristol Hospital plans to convert a 6,150-square-foot space inside its campus at 41 Brewster Road into a new inpatient senior behavioral health unit to treat patients who are primarily 65 and older...

Biohaven receives FDA's orphan drug designation for Rett syndrome treatment

John Stearns |

New Haven-based Biohaven Pharmaceutical Holding Co. Ltd. said its investigational compound has been granted orphan drug designation by the U.S. Food and Drug Administration to treat patients with...

Starling Physicians debuts access center for dialysis patients

John Stearns |

Starling Physicians has completed a project announced earlier this year to relocate and expand its access center for patients who receive kidney dialysis.

Alex's Lemonade Stand Foundation awards $250K grant to Yale researchers for pediatric cancer work

John Stearns |

Alex's Lemonade Stand Foundation (ALSF), a nonprofit dedicated to finding cures for children with cancer, has awarded 19 innovation grants to leading pediatric oncologists across the country,...

GOP still trying, but Blumenthal says Obamacare repeal in 'total disarray'


The Senate returns from its Fourth of July break this week without a firm strategy on how to move forward on a health care bill that has little public support and has split Republicans.

FDA approves Z-Medica's severe-bleeding control device

John Stearns |

Wallingford-based Z-Medica LLC, a developer and marketer of bleeding-control devices, has received Food and Drug Administration approval to market and sell a new product for controlling the most...

Meriden's Protein Sciences to be acquired by Sanofi

Patricia Daddona |

Paris pharmaceutical company Sanofi is buying Meriden-based Protein Sciences for up to $750 million, the company announced Tuesday.

Matulaniec leads TOMZ Corp.'s youth movement

John Stearns |

Tom Matulaniec was 8 when he began helping his father at his Berlin company, TOMZ Corp., launching a 23-year journey that in April would see him named president of the manufacturer specializing in...

Growing number of states press opioid suits against Stamford's Purdue Pharma


Stamford-based Purdue Pharma, the maker of pain-killer OxyContin, is the target of an increasing number of states, counties and cities suing the pharmaceutical firm, alleging it is partly to blame...

Copyright 2017 New England Business Media